Borderline ovarian tumor patient registry in Korea
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This is a registry, meaning researchers collect and organize past medical information from people diagnosed with borderline ovarian tumors in Korea. It helps doctors better understand treatment patterns and outcomes over time, which may improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with a borderline ovarian tumor (a tumor that is not clearly cancer)
- Your diagnosis, treatment, and follow-up happened at hospitals in Korea between November 1994 and February 2015, or surgery for this condition happened in Korea starting March 2015
- You had main treatment for your borderline ovarian tumor
- You had follow-up for at least 6 months at each hospital involved
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and organizes information from people who have ovarian cancer. It may help researchers better understand ovarian cancer and how patients are treated.
This is a research study that builds a registry (a record) of women in Korea with cervical, endometrial, or ovarian cancer. It may help researchers better understand these cancers and plan future studies.
This study uses ultrasound and blood tests to help doctors tell the difference between a borderline ovarian tumor and an early-stage invasive ovarian cancer. If you have a cyst found on your ovary that might be one of these types, joining could help improve diagnosis.
This study collects information about people with rare cancers in Korea to better understand these diseases. It may help improve future care and treatments.
This registry collects information from people with advanced ovarian or endometrial cancer to better understand care and outcomes. It may help researchers and doctors learn which treatments work best for different patients.
This study collects information from people who have had specific types of ovarian or testicular stromal tumors. It does not test a new drug; it helps doctors understand these rare tumors better over time.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.